HomeNews

News

Global Markets

FDA refuses to approve Gilead HIV medication on glass vial concerns

Pharma -
Gilead Sciences, Inc. announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA)...
Global Markets

La Jolla Institute for Immunology and Charles River Laboratories to collaborate on COVID-19 research

Pharma -
Scientists at LJI and Charles River Laboratories, are launching a new project to uncover exactly how different cells in the human immune system respond...
Drug Development

CureVac establishes RNA printer-specific company

Pharma -
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced that it has established...
Global Markets

Rosatom and Chiesi signed an agreement to acquire “green” I-REC certificates

Pharma -
JSC Atomenergopromsbyt (part of the wind energy division of Rosatom) and the Russian division of the Chiesi Group of Companies (Italy) signed an agreement...
Manufacturing

Touchlight and Versameb sign GMP manufacturing supply agreement

Pharma -
Versameb moves forward with its lead asset towards clinical development with an Innovative synthetic doggybone DNA technology which increases quality and yield of mRNA...
Global Markets

Abbott Nutrition recalled more baby formula Similac PM after another report of illness

Pharma -
The U.S. Food and Drug Administration has expanded its recall to include another Similac PM product. The Centers for Disease Control and Prevention (CDC)...
1...656667...125Page 66 of 125
spot_img

Expert Articles

spot_img